Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →

Clinical Trials Directory

Browse and search research studies sourced from ClinicalTrials.gov and our partner researchers.

48,257 studies found

Not Yet Recruiting
Phase II Study of Trastuzumab Rezetecan Combined With Retlirafusp Alfa With or Without CAPOX as...

Conditions: Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma

Tianjin Medical University Cancer Institute & Hospital...

View details
Recruiting
IRE After Chemotherapy for Locally Advanced Pancreatic Cancer

Conditions: IRE

Tianjin Cancer Hospital Airport Hospital Tianjin Tianji...

View details
Not Yet Recruiting
A Phase 2 Study of SGB-9768 in Patients With Paroxysmal Nocturnal Hemoglobinuria

Conditions: PNH - Paroxysmal Nocturnal Hemoglobinuria

Institute of Hematology & Blood Diseases Hospital, Chin...

View details
Recruiting
HCCANANO-HOPE1: IRE After Chemotherapy for Locally Advanced Unresectable Perihilar Cholangiocar...

Conditions: IRE

Tianjin Cancer Hospital Airport Hospital Tianjin Tianji...

View details
Recruiting
A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Solid Tumors

Conditions: Solid Tumors

Tianjin Cancer Hospital Tianjin Tianjin Municipality

View details
Not Yet Recruiting
A Study of Elranatamab for Inhibitor Eradication in Patients With Hemophilia A

Conditions: Hemophilia A With Inhibitors

Chinese Academy of Medical Science and Blood Disease Ho...

View details
Recruiting
Multi-target Drugs Sequential Combination Therapy in Adults Patients With Newly Diagnosed Prima...

Conditions: ITP - Immune Thrombocytopenia

Ethics Committee of Hematology Hospital, Chinese Academ...

View details
Recruiting
A Single-Arm Phase Ⅱ Study of Fluzoparib Maintenance in Platinum-sensitive Advanced Triple-Nega...

Conditions: Platinum-sensitive, TNBC, Triple Negative Breast Cancer, BRCA1/2 Mutation or Not

Tianjin Medical University Cancer Institute and Hospita...

View details
Recruiting
An Exploratory Study on the Efficacy and Safety of Enlonstobart Combined With Concurrent Radiot...

Conditions: Uterine Cervical Neoplasms

Tianjin Cancer Hospital Airport Branch Tianjin

View details
Recruiting
Study of BEBT-507 Injection in Subjects With Polycythemia Vera (PV)

Conditions: Polycythemia Vera

Blood Diseases Hospital, Chinese Academy of Medical Sci...

View details
Recruiting
Phase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia V...

Conditions: Polycythemia Vera (PV)

Institute of Hematology & Blood Diseases Hospital, Chin...

View details
Recruiting
Analysis of Multimodal Psychosomatic Comorbidity Burden in Breast Cancer and Benefit Evaluation...

Conditions: Breast Neoplasms

First Teaching Hospital of Tianjin University of Tradit...

View details
Recruiting
NK Cells Plus ICI for SCLC Maintenance

Conditions: Small Cell Lung Cancer

Tianjin First Central Hospital Tianjin Tianjin Municipa...

View details
Recruiting
Metformin Inhibits DNMT3A Clonal Hematopoiesis in Acute Leukemia

Conditions: DNMT3A Gene Mutation

Blood Diseases Hospital Tianjin Tianjin Municipality

View details
Recruiting
MRD-positive AML Clinical Study

Conditions: AML, Adult

Blood Diseases Hospital Tianjin Tianjin Municipality

View details
Recruiting
Intermediate-dose HAD Regimen for CEBPA Double-mutated AML

Conditions: AML

Blood Hospital Tianjin Tianjin Municipality

View details
Not Yet Recruiting
A Study on the Efficacy of Different Doses of Oryz-Aspergillus Enzyme And Pancreatin Tablet in...

Conditions: Pancreatic Exocrine Insufficiency, Adul

Tianjin Medical University Cancer Institute and Hospita...

View details
Recruiting
Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leuke...

Conditions: AML, RUNX1-RUNX1T1 Fusion Protein Expression

Blood Diseases Hospital Tianjin Tianjin Municipality

View details
Not Yet Recruiting
BCMA/GPRC5D Trispecific Antibody Treatment for Newly Diagnosed Amyloidosis (AL-004)

Conditions: AL Amyloidosis

Institute of Hematology and Blood Diseases Hospital Chi...

View details
Recruiting
HY001N for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy.

Conditions: Autoimmune Hemolytic Anemia (AIHA)

Institute of Hematology & Blood Diseases Hospital Tianj...

View details
Recruiting
A Study of Neoadjuvant Tislelizumab Plus Lenvatinib in Resectable HCC at High Risk of Recurrenc...

Conditions: HCC - Hepatocellular Carcinoma

Tianjin Medical University Cancer Institute & Hospital...

View details
Not Yet Recruiting
To Explore a Single-arm Phase II Study on Intestinal Microbiota Transplantation Combined With N...

Conditions: Locally Advanced Rectal Cancer (LARC)

Tianjin Medical University Cancer Institute & Hospital...

View details
Recruiting
CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL)

Tianjin Medical University Cancer Insititute & Hospital...

View details
Active Not Recruiting
AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC

Conditions: Resectable Non-small Cell Lung Cancer

Tianjin Medical University Cancer Institute & Hospital...

View details